• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于注射给药的溶致液晶。

Lyotropic liquid crystals for parenteral drug delivery.

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad 380009, India; Department of Pharmaceutics & Pharm, Technology, K. B. Institute of Pharmaceutical Education and Research, Kadi Sarva Vishwavidyalaya, Gandhinagar 382023, Gujarat, India.

Department of Pharmaceutics, SVKM's Narsee Monjee Institute of Management Studies (NMIMS), Shirpur, India.

出版信息

J Control Release. 2022 Sep;349:533-549. doi: 10.1016/j.jconrel.2022.06.062. Epub 2022 Jul 20.

DOI:10.1016/j.jconrel.2022.06.062
PMID:35792188
Abstract

The necessity for long-term treatments of chronic diseases has encouraged the development of novel long-acting parenteral formulations intending to improve drug pharmacokinetics and therapeutic efficacy. Lately, one of the novel approaches has been developed based on lipid-based liquid crystals. The lyotropic liquid crystal (LLC) systems consist of amphiphilic molecules and are formed in presence of solvents with the most common types being cubic, hexagonal and lamellar mesophases. LC injectables have been recently developed based on polar lipids that spontaneously form liquid crystal nanoparticles in aqueous tissue environments to create the in-situ long-acting sustained-release depot to provide treatment efficacy over extended periods. In this manuscript, we have consolidated and summarized the various type of liquid crystals, recent formulation advancements, analytical evaluation, and therapeutic application of lyotropic liquid crystals in the field of parenteral sustained release drug delivery.

摘要

长期治疗慢性病的必要性促使人们开发新型长效注射制剂,旨在改善药物药代动力学和治疗效果。最近,一种新的方法是基于基于脂质的液晶发展而来的。溶致液晶(LLC)体系由两亲性分子组成,并在溶剂存在下形成,最常见的类型是立方、六方和层状中间相。最近开发了基于极性脂质的 LC 注射剂,它们在水组织环境中自发形成液晶纳米颗粒,以形成原位长效持续释放库,从而在延长的时间内提供治疗效果。在本文中,我们总结了各种类型的液晶、最近的制剂进展、溶致液晶的分析评价以及在注射缓控释药物传递领域的治疗应用。

相似文献

1
Lyotropic liquid crystals for parenteral drug delivery.用于注射给药的溶致液晶。
J Control Release. 2022 Sep;349:533-549. doi: 10.1016/j.jconrel.2022.06.062. Epub 2022 Jul 20.
2
Cubic and hexagonal liquid crystals as drug delivery systems.立方相和六方相液晶作为药物递送系统。
Biomed Res Int. 2014;2014:815981. doi: 10.1155/2014/815981. Epub 2014 Jun 5.
3
Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.控制基于脂质的液晶中间相中的分子传递和持续药物释放。
J Control Release. 2014 Aug 28;188:31-43. doi: 10.1016/j.jconrel.2014.05.052. Epub 2014 Jun 6.
4
Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal.基于溶致液晶的仿生系统研究聚焦
Molecules. 2017 Mar 7;22(3):419. doi: 10.3390/molecules22030419.
5
Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.溶致液晶相:药物传递和生物医学应用。
Int J Pharm. 2023 Nov 25;647:123546. doi: 10.1016/j.ijpharm.2023.123546. Epub 2023 Oct 25.
6
In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin.微乳液的原位相转变为注射用的溶致液晶载体,用于抗肿瘤药物蟾毒灵。
Colloids Surf B Biointerfaces. 2019 Jan 1;173:217-225. doi: 10.1016/j.colsurfb.2018.09.023. Epub 2018 Sep 11.
7
Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.基于溶致液晶的可注射原位形成凝胶用于持续术后镇痛。
Acta Biomater. 2018 Feb;67:99-110. doi: 10.1016/j.actbio.2017.11.057. Epub 2017 Dec 8.
8
Self-assembling in situ gel based on lyotropic liquid crystals containing VEGF for tissue regeneration.基于含有 VEGF 的溶致液晶的自组装原位凝胶用于组织再生。
Acta Biomater. 2019 Nov;99:84-99. doi: 10.1016/j.actbio.2019.09.011. Epub 2019 Sep 12.
9
Nitric oxide-sensing actuators for modulating structure in lipid-based liquid crystalline drug delivery systems.用于调节基于脂质的液晶药物传递系统结构的一氧化氮感应执行器。
J Colloid Interface Sci. 2017 Dec 15;508:517-524. doi: 10.1016/j.jcis.2017.08.079. Epub 2017 Aug 24.
10
Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.口服和透皮给药系统:基于脂质的溶致液晶的作用
Drug Des Devel Ther. 2017 Feb 13;11:393-406. doi: 10.2147/DDDT.S103505. eCollection 2017.

引用本文的文献

1
Responsive Nano-structured Cubosomes: Advancements and Therapeutic Applications.响应性纳米结构立方液晶:进展与治疗应用
Adv Pharm Bull. 2025 May 31;15(2):284-292. doi: 10.34172/apb.025.43330. eCollection 2025 Jul.
2
SDF-1α loaded lipid liquid crystalline hydrogel accelerates diabetic wound healing in in vitro and in vivo models.负载基质细胞衍生因子-1α的脂质液晶水凝胶在体外和体内模型中均能加速糖尿病伤口愈合。
Sci Rep. 2025 Jul 18;15(1):26188. doi: 10.1038/s41598-025-10756-x.
3
Advanced Artificial Intelligence Technologies Transforming Contemporary Pharmaceutical Research.
先进人工智能技术变革当代药物研发
Bioengineering (Basel). 2025 Mar 31;12(4):363. doi: 10.3390/bioengineering12040363.
4
Exploiting the potential of forming liquid crystals: development and performance of long-acting depots for peptide drug thymosin alpha 1 subcutaneous administration.利用形成液晶的潜力:用于肽类药物胸腺素α1皮下给药的长效贮库的开发与性能
Drug Deliv. 2025 Dec;32(1):2460708. doi: 10.1080/10717544.2025.2460708. Epub 2025 Mar 11.
5
Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals.眼部药物递送的最新进展:对溶致液晶的见解
Pharmaceuticals (Basel). 2024 Oct 2;17(10):1315. doi: 10.3390/ph17101315.
6
Effect of DMSO Addition on the Hexagonal Phase of the System Triton X/Water.二甲基亚砜添加对Triton X/水体系六方相的影响。
Langmuir. 2024 Oct 22;40(42):21985-21994. doi: 10.1021/acs.langmuir.4c01937. Epub 2024 Oct 11.
7
Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications.立方液晶作为药物载体的应用新进展,特别关注局部应用
J Lipids. 2024 Jul 10;2024:2683466. doi: 10.1155/2024/2683466. eCollection 2024.
8
Key Challenges, Influencing Factors, and Future Perspectives of Nanosuspensions in Enhancing Brain Drug Delivery.纳米混悬剂增强脑内药物递送的关键挑战、影响因素和未来展望。
Curr Pharm Des. 2024;30(32):2524-2537. doi: 10.2174/0113816128317347240625105501.
9
Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing.通过皮肤屏障、药物递送系统和个体化给药来提高药物疗效的局部给药策略。
Front Pharmacol. 2024 Jan 16;14:1333986. doi: 10.3389/fphar.2023.1333986. eCollection 2023.
10
Development of Sustained Release Formulations Based on Lipid-Liquid Crystal to Control the Release of Deoxycholate: In Vitro and In Vivo Assessment.基于脂质液晶的控释制剂的研制以控制脱氧胆酸盐的释放:体外和体内评估
AAPS PharmSciTech. 2023 Nov 10;24(8):224. doi: 10.1208/s12249-023-02677-7.